Drug treatment of personality disorders - An evaluation of the AGATE working group;Medikamentöse therapie bei persönlichkeitsstörungen - Eine auswertung der AGATE

Psychopharmakotherapie

Volumn 16, Issue 6, 2009, Pages 246-250

  Wittmann, Markus ^a   Hausner, Helmut ^a   Brauner, Sven ^b   Hajak, Göran ^a   Haen, Ekkehard ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^b Bezirkskrankenhaus Augsburg   (Germany)

Author keywords

AGATE; Drug therapy; Personality disorder

Indexed keywords

AMITRIPTYLINE; CHLORPROTHIXENE; CITALOPRAM; DOXEPIN; ESCITALOPRAM; FLUOXETINE; FLUPENTIXOL; LEVOMEPROMAZINE; MELPERONE; MIRTAZAPINE; OLANZAPINE; PAROXETINE; PERAZINE; PIPAMPERONE; PROMETHAZINE; QUETIAPINE; RISPERIDONE; SERTRALINE; TRIMIPRAMINE; VENLAFAXINE;

ARTICLE; BORDERLINE STATE; FEMALE; GERMANY; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HOSPITAL; PERSONALITY DISORDER; POLYPHARMACY; PSYCHIATRIC DIAGNOSIS;

EID: 71749083862     PISSN: 09446877     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Abraham PF, Calabrese JR. Evidenced-based pharmacologic treatment of borderline personality disorder: a shift from SSRIs to anticonvulsants and atypical antipsychotics? J Affect Disord 2008;111:21-30. Epub 2008 Mar 4.
2. Adityanjee, Romine A, Brown E, Thuras P, et al. Quetiapine in patients with borderline personality disorder: an open-label trial. Ann Clin Psychiatry 2008;20:219-226
3. Bellino S, Paradiso E, Bogetto F. Efficacy and tolerability of pharmacotherapies for borderline personality disorder. CNS Drugs. 2008;22:671-672 (Pubitemid 351950098)
4. Binks CA, Fenton M, McCarthy L, Lee T, et al. Pharmacological interventions for people with borderline personality disorder. Cochrane Database Syst Rev 2006;(1):CD005653.
5. Coid J, Yang M, Tyrer P, Roberts A, et al. Prevalence and correlates of personality disorder in Great Britain. Br J Psychiatry 2006;188:423-431
6. Gjerden P, Bramness JG, Slørdal L. The use and potential abuse of anticholinergic antiparkinson drugs in Norway: a pharmacoepidemiological study. Br J Clin Pharmacol 2009;67:228-233 Epub 2008 Dec 16.
7. Haen E. AGATE - Qualitätssicherung in der Psychopharmakotherapie. Neurotransmitter 2009;7/8:34-43.
8. Herpertz SC, Steinmeyer EM, Saß H. Patterns of comorbidity among DSM-III-R and ICD-10 personality disorders as observed with a new inventory for the assessment of personality disorders. Eur Arch Psychiatry Clin Neuroscience 1994;244:161-169
9. Loranger AW, Sartorius N, Andreoli A, Berger P, et al. The International Personality Disorder Examination. The World Health Organization/Alcohol, Drug Abuse and Mental Health Administration international pilot study of personality disorders. Arch Gen Psychiatry 1994;51:215-224
10. Maier W, Lichtermann D, Klingler T, Heun R. Prevalences of personality disorders (DSM-III-R) in the community. J Personal Disord 1992;6:187-196
11. Ngo A, Ciranni M, Olson KR. Acute quetiapine overdose in adults: a 5-year retrospective case series. Ann Emerg Med 2008;52:541-547 Epub 2008 Apr 23.
12. Oldham JM, Skodol AE, Kellman D, Hyler SE, et al. Diagnosis of DSM-III-R personality disorders by two structured interviews: Patterns of comorbidity. Am J Psychiatry 1992;149:213-220
13. Perrella C, Carrus D, Costa E, Schifano F. Quetiapine for the treatment of borderline personality disorder; an open-label study. Prog Neuropsychopharmacol Biol Psychiatry 2007;31:158-163 Epub 2006 Oct 11. (Pubitemid 44959269)
14. Van den Eynde F, Senturk V, Naudts K, Vogels C, et al. Efficacy of quetiapine for impulsivity and affective symptoms in borderline personality disorder. J Clin Psychopharmacol 2008;28:147-155
15. Wittmann M, Hausner H, Hajak G, Haen E. Verordnungshäufigkeiten und Dosierungen von Neuroleptika. Psychopharmakotherapie 2007;6:243-244
16. Zimmerman M, Coryell W. DSM-III personality disorder diagnoses in a non-patient sample. Demographic correlates and comorbidity. Arch Gen Psychiatry 1989;46:682-689
17. Zimmerman M, Rothschild L, Chelminski I. The Prevalence of DSM-IV personality disorders in psychiatric outpatients. Am J Psychiatry 2005;162:1911-1918 (Pubitemid 41428621)